Matches in Nanopublications for { ?s ?p "[Further, we characterized the direct in vitro effects of the TLR9 agonist, CpG oligodeoxynucleotide (ODN), commonly used as a vaccine adjuvant in cancer immunotherapy, on glioma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP215927.RAtYhUl0JJu8TgOWL_mNjocdN1iyShe8QUbWbfSeBGKAM130_assertion description "[Further, we characterized the direct in vitro effects of the TLR9 agonist, CpG oligodeoxynucleotide (ODN), commonly used as a vaccine adjuvant in cancer immunotherapy, on glioma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215927.RAtYhUl0JJu8TgOWL_mNjocdN1iyShe8QUbWbfSeBGKAM130_provenance.
- NP910104.RA0UmCZQLhR0iSBiyobYLBKNEiFfqWBh_-fqfrD5FES1E130_assertion description "[Further, we characterized the direct in vitro effects of the TLR9 agonist, CpG oligodeoxynucleotide (ODN), commonly used as a vaccine adjuvant in cancer immunotherapy, on glioma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910104.RA0UmCZQLhR0iSBiyobYLBKNEiFfqWBh_-fqfrD5FES1E130_provenance.